GENEVA, Feb. 16 -- MERZ PHARMA GMBH & CO. KGAA (Eckenheimer LandstraBe 10060318 Frankfurt am Main) filed a patent application (PCT/EP2024/072585) for "LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF" on Aug 09, 2024. With publication no. WO/2025/032220, the details related to the patent application was published on Feb 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): FINK, Klaus (c/o Eckenheimer LandstraBe 10060318 Frankfurt am Main), TAYLOR, Harold Victor (c/o Eckenheimer LandstraBe 10060318 Frankfurt am Main), EISELE, Karl-Heinz (c/o Eckenheimer LandstraBe 10060318 Frankfurt am Main)...